BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, Fugazzola P, Tomasoni M, Glehen O, Catena F, Yonemura Y, Ansaloni L. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg. 2018;51:120-127. [PMID: 29413875 DOI: 10.1016/j.ijsu.2018.01.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Feng Q, Long D, Du MS, Wang XS, Li ZS, Zhao YL, Qian F, Wen Y, Yu PW, Shi Y. Short-Term Clinical Efficacy of Neoadjuvant Chemotherapy Combined With Laparoscopic Gastrectomy for Locally Advanced Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Propensity Score-Matched Study. Front Oncol 2021;11:690662. [PMID: 34660265 DOI: 10.3389/fonc.2021.690662] [Reference Citation Analysis]
2 Li CC, Yeh YS, Chen YC, Su WC, Chang TK, Tsai HL, Huang CW, Ma CJ, Yin TC, Chen PJ, Wang JY. Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy. J Oncol 2022;2022:3719241. [PMID: 35345514 DOI: 10.1155/2022/3719241] [Reference Citation Analysis]
3 Coccolini F, Fugazzola P, Ansaloni L, Sartelli M, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Catena F. Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy. Acta Biomed 2018;89:104-9. [PMID: 30561427 DOI: 10.23750/abm.v89i8-S.7904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Schiffmann LM, Loeser H, Jacob AS, Maus M, Fuchs H, Zhao Y, Tharun L, Essakly A, Iannos Damanakis A, Zander T, Büttner R, Schröder W, Bruns C, Quaas A, Gebauer F. Dickkopf-2 (DKK2) as Context Dependent Factor in Patients with Esophageal Adenocarcinoma. Cancers (Basel) 2020;12:E451. [PMID: 32075129 DOI: 10.3390/cancers12020451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sah BK, Xu W, Zhang B, Zhang H, Yuan F, Li J, Liu W, Yan C, Li C, Yan M, Zhu Z. Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China. Front Oncol 2020;10:567529. [PMID: 33537232 DOI: 10.3389/fonc.2020.567529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kurtom S, Kaplan BJ. Esophagus and Gastrointestinal Junction Tumors. Surg Clin North Am 2020;100:507-21. [PMID: 32402297 DOI: 10.1016/j.suc.2020.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li Z, Jia Y, Zhu H, Xing X, Pang F, Shan F, Li S, Wang D, Zhao F, Ma T, Wang S, Ji J. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Gastric Cancer 2021;24:1342-54. [PMID: 34406546 DOI: 10.1007/s10120-021-01207-3] [Reference Citation Analysis]
8 Choi S, Hyung WJ. Modern surgical therapy for gastric cancer-Robotics and beyond. J Surg Oncol 2022;125:1142-50. [PMID: 35481911 DOI: 10.1002/jso.26841] [Reference Citation Analysis]
9 Watson S, de la Fouchardière C, Kim S, Cohen R, Bachet JB, Tournigand C, Ferraz JM, Lefevre M, Colin D, Svrcek M, Meurisse A, Louvet C. Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST). Eur J Cancer 2019;107:46-52. [PMID: 30529902 DOI: 10.1016/j.ejca.2018.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li N, Wang X, Tang Y, Zhao D, Chi Y, Yang L, Jiang L, Jiang J, Shi J, Liu W, Ren H, Fang H, Tang Y, Chen B, Lu N, Jing H, Qi S, Wang S, Liu Y, Song Y, Li Y, Jin J. Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy. Chin J Cancer Res 2021;33:447-56. [PMID: 34584370 DOI: 10.21147/j.issn.1000-9604.2021.04.02] [Reference Citation Analysis]
11 Jin P, Liu H, Ma FH, Ma S, Li Y, Xiong JP, Kang WZ, Hu HT, Tian YT. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion . World J Clin Cases 2021; 9(29): 8718-8728 [PMID: 34734050 DOI: 10.12998/wjcc.v9.i29.8718] [Reference Citation Analysis]
12 Yang L, Sun J, Yu X, Li Y, Li M, Liu J, Wang X, Shi G. Diagnosis of Serosal Invasion in Gastric Adenocarcinoma by Dual-Energy CT Radiomics: Focusing on Localized Gastric Wall and Peritumoral Radiomics Features. Front Oncol 2022;12:848425. [PMID: 35387116 DOI: 10.3389/fonc.2022.848425] [Reference Citation Analysis]
13 Wu C, Wang N, Zhou H, Wang T, Mao Q, Zhang X, Zhao D. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer. J Gastrointest Surg 2020;24:1278-89. [PMID: 31140064 DOI: 10.1007/s11605-019-04257-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Ge R, Liu K, Zhang W, Yang K, Chen X, Zhao L, Zhou Z, Hu J, Pan J. The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/9511066] [Reference Citation Analysis]
15 Ao S, Wang Y, Song Q, Ye Y, Lyu G. Current status and future perspectives on neoadjuvant therapy in gastric cancer. Chin J Cancer Res 2021;33:181-92. [PMID: 34158738 DOI: 10.21147/j.issn.1000-9604.2021.02.06] [Reference Citation Analysis]
16 Xing J, Wang Y, Shan F, Li S, Jia Y, Ying X, Zhang Y, Li Z, Ji J. Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer. Eur J Surg Oncol 2021;47:2023-30. [PMID: 33663942 DOI: 10.1016/j.ejso.2021.02.002] [Reference Citation Analysis]
17 Yu D, Wang Z, He T, Yang L. Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study. Front Surg 2022;9:842828. [DOI: 10.3389/fsurg.2022.842828] [Reference Citation Analysis]
18 Chen YH, Xiao J, Chen XJ, Wang HS, Liu D, Xiang J, Peng JS. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastroenterol 2020; 26(19): 2427-2439 [PMID: 32476803 DOI: 10.3748/wjg.v26.i19.2427] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Xiang L, Jin S, Zheng P, Maswikiti EP, Yu Y, Gao L, Zhang J, Zhang Y, Chen H. Risk Assessment and Preventive Treatment for Peritoneal Recurrence Following Radical Resection for Gastric Cancer. Front Oncol 2021;11:778152. [PMID: 35047394 DOI: 10.3389/fonc.2021.778152] [Reference Citation Analysis]
20 Zhou Z, Zhang M, Liao C, Zhang H, Yang Q, Yang Y. Computed Tomography Texture Features and Risk Factor Analysis of Postoperative Recurrence of Patients with Advanced Gastric Cancer after Radical Treatment under Artificial Intelligence Algorithm. Comput Intell Neurosci 2022;2022:1852718. [PMID: 35655504 DOI: 10.1155/2022/1852718] [Reference Citation Analysis]
21 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Ma F, Wang B, Xue L, Kang W, Li Y, Li W, Liu H, Ma S, Tian Y. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach. J Cancer Res Clin Oncol. 2020;146:2135-2142. [PMID: 32306127 DOI: 10.1007/s00432-020-03214-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
23 Kumar NA, Desouza A, Bhandare MS, Murugan JR, Khandelwal G, Chaudhari V, Ostwal V, Shrikhande SV. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach. Langenbecks Arch Surg 2021;406:613-21. [PMID: 33242137 DOI: 10.1007/s00423-020-02020-9] [Reference Citation Analysis]
24 Akagunduz B, Demir M, Atcı MM. Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT. J Gastrointest Cancer 2021. [PMID: 34263428 DOI: 10.1007/s12029-021-00664-4] [Reference Citation Analysis]
25 Jiang D, Shu C, Zhang W, Sun L, Zhang M, He Y, Owen G, Jin W, He D, Deng X, Liu X. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy. Virchows Arch 2021;478:231-40. [PMID: 32588133 DOI: 10.1007/s00428-020-02878-6] [Reference Citation Analysis]
26 Crimì F, Bao QR, Mari V, Zanon C, Cabrelle G, Spolverato G, Pucciarelli S, Quaia E. Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma. Tomography 2022;8:1196-207. [DOI: 10.3390/tomography8030098] [Reference Citation Analysis]
27 Li Z, Shan F, Ying X, Zhang Y, E JY, Wang Y, Ren H, Su X, Ji J. Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2019;154:1093-101. [PMID: 31553463 DOI: 10.1001/jamasurg.2019.3473] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
28 Shin HJ, Choi YO, Roh CK, Son SY, Hur H, Han SU. ASO Author Reflections: Prediction of Survival Outcomes Based on Preoperative Clinical Parameters in Gastric Cancer. Ann Surg Oncol 2021. [PMID: 33682019 DOI: 10.1245/s10434-021-09785-3] [Reference Citation Analysis]
29 Zhou PZ, Gao L, Wu W, Hao YX. Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC. Pak J Med Sci 2021;37:1890-5. [PMID: 34912413 DOI: 10.12669/pjms.37.7.4265] [Reference Citation Analysis]
30 Nakauchi M, Vos E, Tang LH, Gonen M, Janjigian YY, Ku GY, Ilson DH, Maron SB, Yoon SS, Brennan MF, Coit DG, Strong VE. Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence. Ann Surg Oncol 2021;28:4829-38. [PMID: 33566242 DOI: 10.1245/s10434-021-09624-5] [Reference Citation Analysis]
31 Anker CJ, Dragovic J, Herman JM, Bianchi NA, Goodman KA, Jones WE, Kennedy TJ, Kumar R, Lee P, Russo S, Sharma N, Small W, Suh WW, Tchelebi LT, Jabbour SK. Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines. International Journal of Radiation Oncology*Biology*Physics 2021;109:186-200. [DOI: 10.1016/j.ijrobp.2020.08.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gong W, Zeng J, Ji J, Jia Y, Jia S, Sanders AJ, Jiang WG. EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance. Biomolecules 2021;11:547. [PMID: 33917939 DOI: 10.3390/biom11040547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Qin Y, Deng Y, Jiang H, Hu N, Song B. Artificial Intelligence in the Imaging of Gastric Cancer: Current Applications and Future Direction. Front Oncol 2021;11:631686. [PMID: 34367946 DOI: 10.3389/fonc.2021.631686] [Reference Citation Analysis]
34 Liao XL, Liang XW, Pang HY, Yang K, Chen XZ, Chen XL, Liu K, Zhao LY, Zhang WH, Hu JK. Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis. Front Oncol 2021;11:704244. [PMID: 34422658 DOI: 10.3389/fonc.2021.704244] [Reference Citation Analysis]
35 Rinninella E, Strippoli A, Cintoni M, Raoul P, Vivolo R, Di Salvatore M, Genco E, Manfredi R, Bria E, Tortora G, Gasbarrini A, Pozzo C, Mele MC. Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study. Nutrients 2021;13:960. [PMID: 33809587 DOI: 10.3390/nu13030960] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Shannon AB, Straker RJ 3rd, Keele L, Fraker DL, Roses RE, Miura JT, Karakousis GC. Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer. Ann Surg Oncol 2021. [PMID: 34601642 DOI: 10.1245/s10434-021-10803-7] [Reference Citation Analysis]
37 Xie K, Cui Y, Zhang D, He W, He Y, Gao D, Zhang Z, Dong X, Yang G, Dai Y, Li Z. Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study. Front Oncol 2021;11:770758. [PMID: 35070974 DOI: 10.3389/fonc.2021.770758] [Reference Citation Analysis]
38 Guo D, Zheng K. Effect of Prophylactic Radiotherapy on Patients with Stage II-III Esophageal Cancer after Esophageal Cancer Radical Operation and Influencing Factors in Its Recurrence. J Oncol 2021;2021:7462012. [PMID: 34462636 DOI: 10.1155/2021/7462012] [Reference Citation Analysis]
39 Zhou K, Wang A, Wei J, Ji K, Li Z, Ji X, Fu T, Jia Z, Wu X, Zhang J, Bu Z. The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy. Front Oncol 2021;11:789104. [PMID: 35083146 DOI: 10.3389/fonc.2021.789104] [Reference Citation Analysis]
40 Ma L, Zhang H. Machine learning algorithm of ultrasound-mediated intestinal function recovery and nursing efficacy analysis of lower gastrointestinal malignant tumor after surgery. Pak J Med Sci 2021;37:1662-6. [PMID: 34712302 DOI: 10.12669/pjms.37.6-WIT.4866] [Reference Citation Analysis]
41 Li N, Xiang X, Zhao D, Wang X, Tang Y, Chi Y, Yang L, Jiang L, Jiang J, Shi J, Liu W, Fang H, Tang Y, Chen B, Lu N, Jing H, Qi S, Wang S, Liu Y, Song Y, Li Y, Zhang L, Jin J. Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09297-7] [Reference Citation Analysis]
42 Zhai J, Shen J, Xie G, Wu J, He M, Gao L, Zhang Y, Yao X, Shen L. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37-43. [PMID: 30978440 DOI: 10.1016/j.canlet.2019.04.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 14.7] [Reference Citation Analysis]
43 Li Z, Xiao Q, Wang Y, Wang W, Li S, Shan F, Zhou Z, Ji J. A Modified ypTNM Staging System-Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy. Cancer Manag Res 2020;12:2047-55. [PMID: 32256112 DOI: 10.2147/CMAR.S236696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Wang K, Ren Y, Ma Z, Li F, Cheng X, Xiao J, Zhang S, Yu Z, Yang H, Zhou H, Li Y, Liu H, Jiao ZY. Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) as preoperative and postoperative chemotherapy compared with surgery followed by chemotherapy for patients with locally advanced gastric cancer: a propensity score-based analysis. Cancer Manag Res 2019;11:3009-20. [PMID: 31114348 DOI: 10.2147/CMAR.S200883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wang Y, He K, Zhou Z, Zhong Y, Li G, Lu J. A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. Cancer Manag Res 2020;12:8491-6. [PMID: 32982442 DOI: 10.2147/CMAR.S267330] [Reference Citation Analysis]
46 Hu Q, Wang J, Xu W, Shao P, Li G. Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy. Precision Medical Sciences 2021;10:78-82. [DOI: 10.1002/prm2.12038] [Reference Citation Analysis]